Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Adma Biologics Inc | 2,412,542 | 2,457,542 | +45,000 | $35.37M | $44.83M | 33.22% | +$9.46M |
| Cellectis S.A.ADS(CLLS) | 3,281,501 | 3,281,501 | 0 | $9.35M | $15.88M | 11.77% | +$6.53M |
| Palisade Bio, Inc.(PALI) | 0 | 4,500,000 | +4,500,000 | $0 | $10.57M | 7.84% | +$10.57M |
| Taysha Gene Therapies, Inc.(TSHA) | 1,800,556 | 1,800,556 | 0 | $5.89M | $9.90M | 7.34% | +$4.02M |
| Praxis Precision Medicines, Inc.(PRAX) | 31,500 | 33,237 | +1,737 | $1.67M | $9.80M | 7.26% | +$8.13M |
| Sight Sciences, Inc.(SGHT) | 930,000 | 920,000 | -10,000 | $3.20M | $7.30M | 5.41% | +$4.10M |
| Zai Lab LimitedADR(ZLAB) | 400,000 | 400,000 | 0 | $13.56M | $7.06M | 5.23% | -$6.50M |
| Structure Therapeutics IncADS | 0 | 90,000 | +90,000 | $0 | $6.26M | 4.64% | +$6.26M |
| Assembly Biosciences Inc | 175,706 | 175,706 | 0 | $4.50M | $5.98M | 4.43% | +$1.48M |
| Iovance Biotherapeutics, Inc.(IOVA) | 1,500,000 | 1,500,000 | 0 | $3.25M | $4.09M | 3.03% | +$840.0K |
| Spyre Therapeutics, Inc.(SYRE) | 100,000 | 100,000 | 0 | $1.68M | $3.28M | 2.43% | +$1.60M |
| Aura Biosciences, Inc.(AURA) | 572,576 | 572,576 | 0 | $3.54M | $3.12M | 2.31% | -$418.0K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 135,000 | 135,000 | 0 | $4.06M | $3.10M | 2.30% | -$955.8K |
| Oruka Therapeutics, Inc.(ORKA) | 75,000 | 75,000 | 0 | $1.44M | $2.27M | 1.68% | +$831.0K |
| Apogee Therapeutics Inc | 35,000 | 20,000 | -15,000 | $1.39M | $1.51M | 1.12% | +$119.0K |
| Akero Therapeutics Inc | 232,446 | 0 | -232,446 | $11.04M | $0 | — | -$11.04M |
| GameSquare Holdings, Inc.(GAME) | 250,000 | 0 | -250,000 | $169.7K | $0 | — | -$169.7K |
| Insmed Incorporated(INSM) | 158 | 0 | -158 | $22.8K | $0 | — | -$22.8K |
| NRx Pharmaceuticals, Inc.W EXP 05 24 202(NRXP) | 3,000,000 | 0 | -3,000,000 | $4.46M | $0 | — | -$4.46M |